Ling Peng Selected Research

Immune Checkpoint Inhibitors

5/2023	Successful treatment of immune-related cystitis by Chai-Ling-Tang (Sairei-To) in a gastric carcinoma patient: Case report and literature review.
2/2023	Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients.
1/2023	Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
1/2023	PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review).
1/2023	Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.
2/2022	Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
1/2022	Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies.
1/2022	The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer.
9/2021	Programmed cell death 1 inhibitors with or without concurrent brain radiotherapy for lung cancer patients with brain metastases.
9/2021	Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ling Peng Research Topics

Disease

78	Neoplasms (Cancer) 04/2024 - 10/2009
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 07/2010
14	COVID-19 12/2022 - 01/2020
11	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2019
11	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 02/2009
10	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2010
10	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2014
9	Infections 12/2023 - 01/2005
8	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 08/2009
6	Breast Neoplasms (Breast Cancer) 10/2023 - 03/2010
6	Fibrosis (Cirrhosis) 06/2023 - 01/2019
5	Carcinogenesis 11/2023 - 10/2012
4	Adenocarcinoma of Lung 11/2023 - 04/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 07/2019
4	Pneumonia (Pneumonitis) 02/2022 - 01/2020
4	Adenocarcinoma 10/2021 - 01/2014
4	Hypertension (High Blood Pressure) 10/2020 - 01/2016
3	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 01/2012
3	Carcinoma (Carcinomatosis) 05/2023 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2013
3	Critical Illness (Critically Ill) 01/2022 - 01/2020
3	Lung Injury 01/2022 - 01/2020
3	Brain Neoplasms (Brain Tumor) 01/2022 - 06/2020
3	Inflammation (Inflammations) 01/2022 - 10/2020
3	Neutropenia 10/2021 - 01/2019
3	Hand-Foot Syndrome 01/2021 - 11/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 12/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2024 - 01/2024
2	Acute Kidney Injury (Acute Renal Failure) 05/2023 - 08/2016
2	Cystitis 05/2023 - 01/2021
2	Necrosis 01/2023 - 01/2020
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 07/2022 - 10/2021
2	Disease Progression 10/2021 - 07/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

21	Dendrimers (Dendrons)IBA 01/2024 - 08/2009
18	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2020
18	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2012
15	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2014
12	Small Interfering RNA (siRNA)IBA 10/2023 - 08/2009
11	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2016
8	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2014
7	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2017
6	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2009
6	NUPR1 inhibitor ZZW-115IBA 01/2022 - 01/2019
5	Long Noncoding RNAIBA 05/2023 - 01/2019
5	LipidsIBA 01/2023 - 08/2012
5	AlbuminsIBA 08/2022 - 01/2014
5	Intrinsically Disordered ProteinsIBA 10/2021 - 01/2019
4	Messenger RNA (mRNA)IBA 04/2024 - 01/2014
4	LigandsIBA 10/2023 - 01/2021
4	Gemcitabine FDA Link 01/2022 - 04/2010
4	NucleosidesIBA 01/2015 - 12/2010
4	HSP27 Heat-Shock ProteinsIBA 08/2012 - 08/2009
3	CytokinesIBA 01/2024 - 06/2020
3	CollagenIBA 11/2023 - 01/2019
3	PAMAM StarburstIBA 10/2023 - 08/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 03/2014
3	B7-H1 AntigenIBA 09/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2018
3	AntigensIBA 01/2022 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2014
3	Angiotensin IIIBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 06/2020
3	Inosine Diphosphate (IDP)IBA 10/2021 - 01/2019
3	EnzymesIBA 06/2021 - 01/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 06/2015
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 01/2012
3	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2012
3	TriazolesIBA 01/2015 - 10/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2022
2	Lysine (L-Lysine)FDA Link 01/2024 - 01/2023
2	Adenosine Triphosphate (ATP)IBA 11/2023 - 01/2020
2	Becaplermin (PDGF-BB)FDA Link 11/2023 - 06/2020
2	Fibronectins (Fibronectin)IBA 06/2023 - 01/2019
2	Angiogenesis InhibitorsIBA 02/2023 - 01/2020
2	anlotinibIBA 02/2023 - 10/2022
2	Circulating Tumor DNAIBA 01/2023 - 01/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 12/2022 - 01/2020
2	CreatinineIBA 08/2022 - 08/2016
2	Rituximab (Mabthera)FDA Link 07/2022 - 10/2021
2	LipopolysaccharidesIBA 06/2022 - 11/2020
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 06/2020
2	Circular RNAIBA 01/2022 - 01/2021
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2021
2	AntioxidantsIBA 10/2021 - 06/2021

Therapy/Procedure

41	Therapeutics 04/2024 - 03/2010
14	Immunotherapy 10/2023 - 01/2020
11	Drug Therapy (Chemotherapy) 05/2023 - 05/2012
7	Radiotherapy 04/2024 - 06/2020
2	Castration 01/2024 - 03/2012
2	Thoracotomy 01/2023 - 01/2017
2	Molecular Targeted Therapy 01/2023 - 01/2014